{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:34:15Z","timestamp":1791653655844,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1124\/dmd.121.000486","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T16:30:53Z","timestamp":1633105853000},"page":"1063-1069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition"],"prefix":"10.1016","volume":"49","author":[{"given":"Jennifer","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay K.","family":"Holenarsipur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Thanga","family":"Mariappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Panfen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Griffith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.121.000486_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MNH.0b013e32830b5d5d","article-title":"Update on the molecular physiology of organic anion transporters","volume":"17","author":"Ahn","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/dmd.121.000486_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/metabo9110261","article-title":"Metabolic profiling of human plasma and urine, targeting tryptophan, tyrosine and branched chain amino acid pathways","volume":"9","author":"Anesi","year":"2019","journal-title":"Metabolites"},{"key":"10.1124\/dmd.121.000486_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/abbi.2000.1764","article-title":"p-Cresol sulfate is the dominant component of urinary myelin basic protein like material","volume":"377","author":"Cao","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.121.000486_bib4","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0026-895X(24)12589-8","article-title":"Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney","volume":"59","author":"Cha","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.121.000486_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000486_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcph.442","article-title":"Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline","volume":"55","author":"Davenport","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000486_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2008.02.085","article-title":"Mechanisms of renal anionic drug transport","volume":"585","author":"El-Sheikh","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.121.000486_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt196893345","article-title":"Apparent effect of probenecid on the distribution of penicillins in man","volume":"9","author":"Gibaldi","year":"1968","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000486_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11095-012-0890-6","article-title":"Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6\u03b2-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects","volume":"30","author":"Imamura","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.121.000486_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/clpt.2010.232","article-title":"Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion","volume":"89","author":"Imamura","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000486_bib11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.113.055475","article-title":"6\u03b2-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3\/SLC22A8, in healthy subjects","volume":"42","author":"Imamura","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000486_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.1552-4604.1990.tb03438.x","article-title":"The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers","volume":"30","author":"Inotsume","year":"1990","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000486_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40262-017-0506-8","article-title":"Renal drug transporters and drug interactions","volume":"56","author":"Ivanyuk","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.121.000486_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0009-9236(95)90173-6","article-title":"Effect of probenecid on the distribution and elimination of ciprofloxacin in humans","volume":"58","author":"Jaehde","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000486_bib15","doi-asserted-by":"crossref","first-page":"19474","DOI":"10.1074\/jbc.M116.745216","article-title":"An organic anion transporter 1 (OAT1)-centered metabolic network","volume":"291","author":"Liu","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.121.000486_bib15a","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1389200218666170724110818","article-title":"Endogenous biomarkers to assess drug-drug interactions by drug transporters and enzymes","volume":"18","author":"Mariappan","year":"2017","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.121.000486_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative prediction of human renal clearance and drug-drug interactions of organic anion transporter substrates using in vitro transport data: a relative activity factor approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000486_bib17","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1093\/ndt\/gfq785","article-title":"Organic anion transporters play an important role in the uptake of p-cresyl sulfate, a uremic toxin, in the kidney","volume":"26","author":"Miyamoto","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/dmd.121.000486_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/dmd.121.000486_bib18a","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1124\/pr.116.013326","article-title":"Biomarkers for in vivo assessment of transporter function","volume":"70","author":"M\u00fcller","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.121.000486_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00125-003-1034-7","article-title":"Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide","volume":"46","author":"Niemi","year":"2003","journal-title":"Diabetologia"},{"key":"10.1124\/dmd.121.000486_bib20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/dmd.121.000486_bib20a","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/cpt.749","article-title":"Endogenous probes for drug transporters: Balancing vision with reality","volume":"103","author":"Rodrigues","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.121.000486_bib21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.18433\/J3M89Q","article-title":"Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver","volume":"17","author":"Sato","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/dmd.121.000486_bib22","doi-asserted-by":"crossref","first-page":"F251","DOI":"10.1152\/ajprenal.00439.2004","article-title":"Molecular physiology of renal organic anion transporters","volume":"290","author":"Sekine","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/dmd.121.000486_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1124\/jpet.118.252643","article-title":"Evidence for the validity of pyridoxic acid (PDA) as a plasma-based endogenous probe for OAT1 and OAT3 function in healthy subjects","volume":"368","author":"Shen","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.121.000486_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/dmd.117.077586","article-title":"Discovery and validation of pyridoxic acid and homovanillic acid as novel endogenous plasma biomarkers of organic anion transporter (OAT) 1 and OAT3 in cynomolgus monkeys","volume":"46","author":"Shen","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000486_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/00498250801927435","article-title":"Physiology, structure, and regulation of the cloned organic anion transporters","volume":"38","author":"Srimaroeng","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.121.000486_bib25a","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11095-018-2416-3","article-title":"Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers","volume":"35","author":"Takehara","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.121.000486_bib27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1124\/dmd.116.071472","article-title":"Investigation of endogenous compounds applicable to drug-drug interaction studies involving the renal organic anion transporters, OAT1 and OAT3, in humans","volume":"44","author":"Tsuruya","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000486_bib28","series-title":"In Vitro Drug Interaction Studies\u2014Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions. Guidance for Industry","article-title":"US Food and Drug Administration","year":"2020"},{"key":"10.1124\/dmd.121.000486_bib29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.phrs.2011.11.003","article-title":"Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3","volume":"65","author":"Uwai","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.121.000486_bib30","first-page":"692","article-title":"Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide","volume":"39","author":"Vree","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.121.000486_bib31","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00018-019-03332-w","article-title":"Kynurenic acid and cancer: facts and controversies","volume":"77","author":"Walczak","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/dmd.121.000486_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/dmd.110.036129","article-title":"Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments","volume":"39","author":"Watanabe","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.121.000486_bib33","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.121.000486_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.apsb.2016.07.013","article-title":"Renal drug transporters and their significance in drug-drug interactions","volume":"6","author":"Yin","year":"2016","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.121.000486_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","article-title":"Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions","volume":"8","author":"Zhang","year":"2016","journal-title":"Genome Med"},{"key":"10.1124\/dmd.121.000486_bib36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1124\/dmd.120.000076","article-title":"Detection of weak organic anion-transporting polypeptide 1B inhibition by probenecid with plasma-based coproporphyrin in humans","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407778X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562407778X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.121.000486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:22:49Z","timestamp":1739956969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562407778X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S009095562407778X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.121.000486","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.121.000486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}